Marco Lobba

514 total citations
9 papers, 372 citations indexed

About

Marco Lobba is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Ecology. According to data from OpenAlex, Marco Lobba has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Ecology. Recurrent topics in Marco Lobba's work include Monoclonal and Polyclonal Antibodies Research (5 papers), CRISPR and Genetic Engineering (3 papers) and Bacteriophages and microbial interactions (3 papers). Marco Lobba is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), CRISPR and Genetic Engineering (3 papers) and Bacteriophages and microbial interactions (3 papers). Marco Lobba collaborates with scholars based in United States. Marco Lobba's co-authors include Jennifer A. Doudna, Matthew B. Francis, Alan M. Marmelstein, Johnathan C. Maza, Gavin J. Knott, Basem Al-Shayeb, Brittney W. Thornton, Junjie Liu, Kyle E. Watters and Daniel Brauer and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.

In The Last Decade

Marco Lobba

9 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Lobba United States 8 298 81 70 69 40 9 372
V. A. Nesmeyanov Russia 10 274 0.9× 65 0.8× 24 0.3× 68 1.0× 19 0.5× 43 441
Lenka Malinovská Czechia 10 212 0.7× 42 0.5× 48 0.7× 84 1.2× 15 0.4× 14 284
Mohammed Naimuddin Japan 12 267 0.9× 101 1.2× 55 0.8× 11 0.2× 17 0.4× 23 358
Mayumi Kanagawa Japan 11 374 1.3× 13 0.2× 41 0.6× 38 0.6× 18 0.5× 22 447
Hadar Amartely Israel 10 216 0.7× 34 0.4× 17 0.2× 16 0.2× 11 0.3× 18 321
Romel Menacho‐Melgar United States 7 203 0.7× 42 0.5× 18 0.3× 18 0.3× 7 0.2× 10 247
Laurence J. Altobell United States 9 238 0.8× 104 1.3× 18 0.3× 42 0.6× 4 0.1× 9 353
Jorick Vanbeselaere Austria 11 261 0.9× 23 0.3× 13 0.2× 90 1.3× 7 0.2× 18 326
Esmeralda Woestenenk Sweden 8 258 0.9× 60 0.7× 17 0.2× 15 0.2× 8 0.2× 10 376
Linda J. Hornstra United States 9 318 1.1× 19 0.2× 59 0.8× 28 0.4× 7 0.2× 9 449

Countries citing papers authored by Marco Lobba

Since Specialization
Citations

This map shows the geographic impact of Marco Lobba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Lobba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Lobba more than expected).

Fields of papers citing papers by Marco Lobba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Lobba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Lobba. The network helps show where Marco Lobba may publish in the future.

Co-authorship network of co-authors of Marco Lobba

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Lobba. A scholar is included among the top collaborators of Marco Lobba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Lobba. Marco Lobba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kendall, Richard, Marco Lobba, Chanez Symister, et al.. (2024). Abstract 5797: Next generation antibody drug conjugates: Multi-payload conjugates targeting multiple mechanisms of cell killing. Cancer Research. 84(6_Supplement). 5797–5797. 1 indexed citations
2.
Lobba, Marco, Daniel Brauer, Alan M. Marmelstein, et al.. (2021). Synthesis of Multi-Protein Complexes through Charge-Directed Sequential Activation of Tyrosine Residues. Journal of the American Chemical Society. 143(34). 13538–13547. 22 indexed citations
3.
Cress, Brady F., et al.. (2021). OUP accepted manuscript. Nucleic Acids Research. 49(6). 3546–3556. 13 indexed citations
4.
Marmelstein, Alan M., et al.. (2020). Tyrosinase-Mediated Oxidative Coupling of Tyrosine Tags on Peptides and Proteins. Journal of the American Chemical Society. 142(11). 5078–5086. 63 indexed citations
5.
Lobba, Marco, Christof Fellmann, Alan M. Marmelstein, et al.. (2020). Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine–Cysteine Bond Formation. ACS Central Science. 6(9). 1564–1571. 71 indexed citations
6.
Knott, Gavin J., Brittney W. Thornton, Marco Lobba, et al.. (2019). Broad-spectrum enzymatic inhibition of CRISPR-Cas12a. Nature Structural & Molecular Biology. 26(4). 315–321. 97 indexed citations
7.
Knott, Gavin J., Brady F. Cress, Junjie Liu, et al.. (2019). Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a. eLife. 8. 47 indexed citations
8.
Hartman, Emily C., et al.. (2018). Experimental Evaluation of Coevolution in a Self-Assembling Particle. Biochemistry. 58(11). 1527–1538. 16 indexed citations
9.
Hartman, Emily C., Christopher M. Jakobson, Marco Lobba, et al.. (2018). Quantitative characterization of all single amino acid variants of a viral capsid-based drug delivery vehicle. Nature Communications. 9(1). 1385–1385. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026